Biotech with Phase 3 Rheumatoid Arthritis &amp; Psoriasis Trials Raises Capital, Now 'Funded Through Catalysts': https://t.co/DtCwkCmwXS

An update on Can-Fite BioPharma's multiple drug treatment trials.

$CANF #Biotech #Arthritis #Psoriasis #stocks @CanFitePharma https://t.co/uFtZNQgGZO